Teva Shares Jump 22% After Swinging To Profit In Q3

Core Insights - Teva Pharmaceutical Industries Limited reported a return to profitability in Q3, with a net profit of $433 million, or $0.37 per share, compared to a net loss of $437 million, or $0.39 per share, in the same quarter last year [1] - The company's net revenue increased by 1 percent in local currency terms and 3 percent year-over-year to $4.48 billion from $4.33 billion [1] Stock Performance - Teva's shares surged 24.91 percent to $21.75, with the stock fluctuating between $22.71 and $24.90 during the trading session [2] - The stock opened at $23.06 and was last seen at $24.67, compared to the previous close of $20.46, with approximately 31.8 million shares traded, more than three times the typical volume of 10 million [2] Historical Stock Fluctuation - Over the past 52 weeks, Teva's stock has fluctuated between $12.47 and $24.90 [3]